IE42308L - 16,16-disubstituted androstenes - Google Patents

16,16-disubstituted androstenes

Info

Publication number
IE42308L
IE42308L IE760412A IE41276A IE42308L IE 42308 L IE42308 L IE 42308L IE 760412 A IE760412 A IE 760412A IE 41276 A IE41276 A IE 41276A IE 42308 L IE42308 L IE 42308L
Authority
IE
Ireland
Prior art keywords
carbon atoms
radicals
radical
alkyl radical
group
Prior art date
Application number
IE760412A
Other versions
IE42308B1 (en
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IE42308L publication Critical patent/IE42308L/en
Publication of IE42308B1 publication Critical patent/IE42308B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Pharmaceutically utilisable 3-ketosteroids which are disubstituted in position 16 and have the formula I <IMAGE> in which R3 are alkyl radicals with 1 to 5 carbon atoms, alkenyl or cycloalkyl radicals with 3 to 6 carbon atoms or phenylalkyl radicals with 1 to 3 carbon atoms in the alkyl radical, it being possible for the phenyl radicals to be substituted, R4 is the hydroxyl group or the radical -OR6 where R6 is an acyl radical with 2 to 7 carbon atoms, an alkyl radical with 1 to 4 carbon atoms, or the benzyl group which can be substituted, and R5 is a hydrogen atom or an alkyl radical with 1 to 5 carbon atoms, it also being possible for R4 and R5, together with the carbon atom to which they are bonded, to form the carbonyl group, are obtained by removing the protective group in the compound of the formula I in which the double bond is in the 5,6 position and the 3-carbonyl group is protected by ketal, hemithioketal or thioketal. The double bond rearranges during the elimination and provides the required 4,5 bond in the final product. The prepared compounds are particularly valuable for the treatment of androgen-dependent skin disorders such as acne and seborrhoea and of other androgen-dependent disorders associated with skin and hair glands. [GB1538227A]
IE412/76A 1975-03-21 1976-03-01 16, 16-disubstituted steroids of the androstene series IE42308B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB11819/75A GB1538227A (en) 1975-03-21 1975-03-21 16,16-disubstituted steroids of the androstene series

Publications (2)

Publication Number Publication Date
IE42308L true IE42308L (en) 1976-09-21
IE42308B1 IE42308B1 (en) 1980-07-16

Family

ID=9993275

Family Applications (1)

Application Number Title Priority Date Filing Date
IE412/76A IE42308B1 (en) 1975-03-21 1976-03-01 16, 16-disubstituted steroids of the androstene series

Country Status (15)

Country Link
JP (2) JPS51118756A (en)
AT (1) AT357700B (en)
AU (1) AU501246B2 (en)
BE (1) BE839751A (en)
CA (1) CA1069498A (en)
CH (2) CH621560A5 (en)
DE (1) DE2610497C2 (en)
DK (1) DK143757C (en)
FR (2) FR2304345A1 (en)
GB (1) GB1538227A (en)
IE (1) IE42308B1 (en)
IL (2) IL49132A (en)
NL (1) NL184111C (en)
SE (2) SE7603410L (en)
ZA (1) ZA761324B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1602960A (en) * 1977-05-25 1981-11-18 Beecham Group Ltd Process for preparing 16,16-disubstituted steroids of the androstene series
DE2943778A1 (en) * 1979-10-26 1981-05-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17-Alpha:alkyl-4,15-androstadiene-3-one derivs. - topical antiandrogens effective against acne, seborrhoea, alopecia and hirsutism
DE3514272A1 (en) * 1985-04-17 1986-10-23 Schering AG, 1000 Berlin und 4709 Bergkamen DERMATICA
JPS63300153A (en) * 1987-05-29 1988-12-07 日本碍子株式会社 Building enamel panel
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
JPH06502161A (en) * 1990-10-31 1994-03-10 ビーチャム・グループ・パブリック・リミテッド・カンパニー Topical compositions containing retinoid penetration enhancers
GB9205194D0 (en) * 1992-03-10 1992-04-22 Smithkline Beecham Plc Novel composition
US20050009797A1 (en) * 2001-12-19 2005-01-13 Mitsuaki Nakamura Androstane derivative having substituent in 7- abd 17--positions
CN108558975B (en) * 2018-04-26 2021-03-02 昆明理工大学 12 beta-hydroxy-androstane 4, 14-diene-16-ketone compound and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853926A (en) * 1973-05-29 1974-12-10 Searle & Co 17{62 -hydroxy-16,16-dimethylester-4-en-3-one

Also Published As

Publication number Publication date
CH631996A5 (en) 1982-09-15
CA1069498A (en) 1980-01-08
NL184111B (en) 1988-11-16
DK143757C (en) 1982-03-22
IL49132A0 (en) 1976-05-31
FR2304345A1 (en) 1976-10-15
DE2610497A1 (en) 1976-10-07
BE839751A (en) 1976-09-20
IL49132A (en) 1980-05-30
JPS6355488B2 (en) 1988-11-02
ZA761324B (en) 1977-02-23
FR2445340B1 (en) 1983-02-11
JPS61178920A (en) 1986-08-11
JPS51118756A (en) 1976-10-18
SE7603410L (en) 1976-09-22
FR2445340A1 (en) 1980-07-25
ATA191376A (en) 1979-12-15
DK143757B (en) 1981-10-05
IE42308B1 (en) 1980-07-16
DK123476A (en) 1976-09-22
FR2304345B1 (en) 1980-11-07
SE7902256L (en) 1979-03-13
NL7602949A (en) 1976-09-23
IL58505A0 (en) 1980-01-31
AU501246B2 (en) 1979-06-14
AU1220776A (en) 1977-09-22
AT357700B (en) 1980-07-25
NL184111C (en) 1989-04-17
GB1538227A (en) 1979-01-10
DE2610497C2 (en) 1986-10-16
JPS625920B2 (en) 1987-02-07
CH621560A5 (en) 1981-02-13

Similar Documents

Publication Publication Date Title
ES8103088A1 (en) Spiro-(dihydrobenzofuranpiperidines and -pyrrolidines) and derivatives thereof, methods for their preparation and medicines containing them.
KR850002740A (en) Method for producing phenylethanolamine derivative
KR900006341A (en) Heterocyclic compounds
IE42308L (en) 16,16-disubstituted androstenes
GB1350420A (en) Alkanedioxy titanium chelates
GB1163737A (en) Improvements in or relating to 7-Dihalomethyl Steroids
GR3023107T3 (en) New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them.
ES8200353A1 (en) Tetrazolyloxycarbon amides, process for their preparation and their use as herbicides.
IE43396L (en) Oxazolidinones
CZ63295A3 (en) 1 alpha-fluoro-25-hydroxy-16-en-23-in-cholecalciferol as such and for the use as a therapeutic active compound, its use for the preparation of a pharmaceutical preparation, process of its preparation and a pharmaceutical preparation based thereon
KR950025035A (en) Kojic acid derivatives
IE781079L (en) Alpha-ethynyl- and alpha-vinyl-3, 4-disubstituted phenylaanines
ES447307A1 (en) Novel process for the preparation of 1-N-(alpha-substituted-omega-aminoacyl)-3{40 -deoxyribostamycin
CA1266641C (en) 16-keto-17-substituted thia-17-alkyl (or alkenyl or alkynyl) androstenes
IE42220L (en) Dibenzocycloheptenylidenepiperidine derivative.
ES8104199A1 (en) Derivatives of 2-benzoyl-4-nitro anilides, their preparation and their use as medicines.
GB1082574A (en) Steroid esters
ES419667A1 (en) Carboamates of 3,4,5-trimethoxy acetophenone oxime their process of preparation and their therapeutic application
AU1450176A (en) Compositions for treatment of cardiac rhythm disturbance
JPS51115918A (en) Germicides for the porposes withowt medical treatment and method for p reparing them
ES380440A1 (en) 22-substituted cardenolideglycosides
ES387208A1 (en) Cardenolide rhamnosides
MD940041A (en) Hydroxamic acids derivatives, compositions on their base, method of control of phytopathogenic fungi and prevention of infection
ES468293A1 (en) A-norandrostane derivatives
IE42065L (en) Dibenzocycloheptenylidenepiperidine derivative.